{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifi233x3vo6j4nu4lbexjxggklb3n24avgb27j4q3q2bgxd5nycri",
    "uri": "at://did:plc:sgbcix3wjir5gnkm6ybi24kf/app.bsky.feed.post/3mmbg3nzlw572"
  },
  "path": "/2026/05/19/repub/miscarriage-patients-have-fewer-treatment-options-in-states-with-abortion-bans-study-shows/",
  "publishedAt": "2026-05-19T18:18:09.000Z",
  "site": "https://floridaphoenix.com",
  "tags": [
    "Abortion Policy",
    "Politics & Law",
    "American College of Obstetricians and Gynecologists",
    "Dobbs",
    "FDA",
    "JAMA",
    "mifepristone",
    "misoprostol",
    "Nicole Freehill"
  ],
  "textContent": "Pregnant patients experiencing miscarriage who live in states with abortion bans have fewer options for healthcare management, according to a new study published by the Journal of the American Medical Association. The study, published May 18, found a shift away from managing miscarriages with a two-drug approach that includes mifepristone — which has been the […]",
  "title": "Miscarriage patients have fewer treatment options in states with abortion bans, study shows"
}